Astellas Pharma saw the highest growth of 1.31% in patent filings in May and 0.86% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.6% and grants by 0.86%. GlobalData’s DataBook provides a comprehensive analysis of Astellas Pharma‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Astellas Pharma has been focused on protecting inventions in United States(US) with 35 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 32% filings and 26% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Japan(JP) patent Office are among the top ten patent offices where Astellas Pharma is filings its patents. Among the top granted patent authorities, Astellas Pharma has 26% of its grants in United States(US), 15% in Israel(IL) and 10% in European Patent Office(EPO).
Roche and Johnson & Johnson could be the strongest competitors for Astellas Pharma
Patents related to rare diseases and cell & gene therapy lead Astellas Pharma's portfolio
Astellas Pharma has the highest number of patents in rare diseases followed by, cell & gene therapy and healthtech. For rare diseases, nearly 32% of patents were filed and 57% of patents were granted in Q2 2024.
Lung cancer related patents lead Astellas Pharma portfolio followed by pancreatic cancer, and ovarian cancer
Astellas Pharma has highest number of patents in lung cancer followed by pancreatic cancer, ovarian cancer, liver cancer, and esophageal cancer. For lung cancer, nearly 4% of patents were filed and 2% of patents were granted in Q2 2024.
For comprehensive analysis of Astellas Pharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
